A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased ...

Up 42% in a year, not including dividends, here’s why ResMed Inc (ASX: RMD) shares can keep charging ahead in 2025.

Jezebel has been the Internet's most treasured source for everything celebrities, sex, and politics...with teeth.

Biologic Pharmamedical invites wellness brands, MLMs, and co-manufacturers to explore how these patented technologies can revolutionize their product lines. From formulation to marketing, Biologic ...

Jonathan Van Ness is getting candid about his weight loss journey. In a vulnerable new video posted to TikTok this week, the ...

You’ve likely heard the term GLP1 when it comes to medications. These are the diabetes treatments now being used as a tool for weight loss. While the results can be dramatic, many are wondering if ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

At 53, she's not only lost over 50 pounds but has successfully maintained her weight loss for over a year. Here's her ...

Ozempic is a brand name semaglutide, a medication used to treat type 2 diabetes. It’s also used as an off-label use for weight loss. Wegovy is another brand name with the same a ...

LA GLP1-RAs have shown at least equal reduction ... of these antibodies result in significant decrease in efficacy of the medication class. LA GLP1-RAs in studies to date appear to be a cost ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.